Transvaginal Mesh Lawsuit News: Federal Appeals Court Asked to Uphold $2 Million Verdict in C.R. Bard Bellwether Trial

New York, New York (PRWEB) June 04, 2015

Transvaginal mesh lawsuits ( ) involving devices manufactured by C.R. Bard, Inc. continue to move forward in courts around the U.S. According to court documents dated June 1st, the plaintiff whose case was selected for the first federal bellwether trial involving C.R. Bard has asked the U.S. Court of Appeals for the Fourth Circuit to uphold the $ 2 million verdict she was awarded by a West Virginia federal court jury. In doing so, the plaintiff asserted that the original trial court was correct when it deemed certain evidence related to the regulatory clearance of the Avaulta Plus mesh product inadmissible. (Cisson v. C.R. Bard Inc., 11-cv-00195)

“Our Firm is representing numerous women who have filed vaginal mesh lawsuits against C.R. Bard, and as a bellwether case, this trial was intended to provide insight into how juries might rule in similar claims involving the company’s products. We will be monitoring this matter closely, and look forward to the appeals court’s decision,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate lawsuits on behalf of women who were allegedly harmed by transvaginal mesh implants.

Transvaginal Mesh Litigations

Court documents indicate that more than 11,000 transvaginal mesh lawsuits are pending against C.R. Bard in the federal multidistrict litigation underway in the U.S. District Court, Southern District of West Virginia, all of which were filed on behalf of women who allegedly experienced severe and life-changing complications following implantation of surgical mesh devices to treat pelvic organ prolapse and stress urinary incontinence. (In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2187)

According to court documents, the litigation’s first bellwether trial concluded in August 2013, with a jury finding that C.R. Bard was liable for the vaginal mesh complications experienced by a woman who received the company’s Avaulta Plus mesh device to treat pelvic organ prolapse. After just 12 hours of deliberations, the panel awarded the plaintiff $ 250,000 in compensatory damages, along with $ 1.75 million in punitive damages.

According to court records, the federal C.R. Bard litigation is just one of seven vaginal mesh proceedings currently underway in the Southern District of West Virginia, where more than 75,000 complaints have been filed. Other proceedings include: In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation – MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation – MDL No. 2326; In Re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation – MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2440; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation – MDL No. 2327; and In Re: Neomedic Pelvic Repair System Products Liability Litigation – MDL No. 2511.

Bernstein Liebhard LLP is also representing vaginal mesh plaintiffs in two multicounty litigations established in New Jersey Superior Court for cases filed in that state against C.R. Bard and Ethicon. Court records indicate that more than 9,500 complaints are currently pending in those proceedings. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10; In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)

Women who have experienced mesh erosion, pain during sexual intercourse, organ damage and other serious complications allegedly due to transvaginal mesh may be eligible to join this litigation. To find out more about filing a transvaginal mesh lawsuit, please visit Bernstein Liebhard LLP’s website or the firm’s Facebook page: To arrange for a free legal consultation, please call 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs’ firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016


ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Sandy A. Liebhard, Esq.

Bernstein Liebhard LLP


More Medication Press Releases

Leave a Reply